NPA-GP: Glucose Outcomes (2021)
Author and Year:
Weinhold K, Miller C, et al, 2015
A randomized controlled trial translating the diabetes prevention program to a university worksite, Ohio, 2012-2014.
Weinhold K, Miller C, Marrero D, Nagaraja H, Focht B, Gascon G
Preventing Chronic Disease
Year of publication:
Randomized Controlled Trial
Risk of Bias Assessment Rating:
Employee of university; aged 18-65 years old; BMI 25.0-50.0 kg/m2; prediabetes; a score of 5 or more on a 7-item ADA risk assessment questionnaire; fasting finger-stick glucose levels of 100 to 125 mg/dL; if fasting finger-stick glucose level was 95 to 99 or 126 to 140 mg/dL did a finger stick HbA1c and if 5.7% to 6.4% eligible.
Completed the Physical Activity Readiness Questionnaire and those who answered positively to 1 or more questions; employees older than 65 years; current diagnosis of type 2 diabetes mellitus; pursuing or recently had weight-loss surgery; taking medication that modifies blood glucose (metformin, corticosteroids); actively participating in a weight-management program; pregnant; breastfeeding; trying to become pregnant; planning to leave employment or move from area within 1 year of study enrollment'.
Evaluate the efficacy of a worksite lifestyle intervention among employees with prediabetes; It was hypothesized that the intervention would facilitate greater reductions in the percentage of weight loss than the usual care (control).
Wtatistician (who generated randomization sequence and allocation) was blinded to treatment assignment; neither participants nor lifestyle coaches were blinded to treatment allocation;
major university in the midwestern United States of America
Source(s) of Funding:
Please specify names of funders:
National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health R34DK093907
Trial Name if applicable: